Tue, February 10, 2009
Mon, February 9, 2009
Sun, February 8, 2009
Fri, February 6, 2009
Thu, February 5, 2009
Wed, February 4, 2009
Tue, February 3, 2009
Mon, February 2, 2009
Sun, February 1, 2009
Sat, January 31, 2009
Fri, January 30, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Progen-Avexa Merger Update
Thu, January 29, 2009
Wed, January 28, 2009
Tue, January 27, 2009

ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009


//health-fitness.news-articles.net/content/2009/ .. ceo-investor-conference-on-february-10-2009.html
Published in Health and Fitness on Tuesday, February 3rd 2009 at 7:41 GMT, Last Modified on 2009-02-03 07:42:28 by Market Wire   Print publication without navigation


SAN DIEGO--([ BUSINESS WIRE ])--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the BIO CEO & Investor Conference 2009 on Tuesday, February 10, 2009, at 10:00 a.m. Eastern Time at The Waldorf=Astoria Hotel in New York City.

A live webcast of ACADIA's presentation will be accessible on the company's website, [ www.acadia-pharm.com ], under the investors section and an archived recording will be available on the website through February 24, 2009.

About ACADIA Pharmaceuticals

ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA is focused on developing a portfolio of its four most advanced product candidates, including pimavanserin in Phase III for Parkinson's disease psychosis, a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, and ACP-106 in IND-track development. All of the product candidates in ACADIA's pipeline emanate from discoveries made using its proprietary drug discovery platform. ACADIA maintains a website at [ www.acadia-pharm.com ] to which ACADIA regularly posts copies of its press releases as well as additional information and through which interested parties can subscribe to receive email alerts.


Publication Contributing Sources

Similar Health and Fitness Publications